Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Idinvest Partners
AddedFeb 13, 2024
UpdatedJul 16, 2026
Idinvest Partners

Idinvest Partners

Inactive

Idinvest Partners, a global private equity and venture capital firm, headquartered in Paris, France.

Location
Paris, Paris, FR
Founded
1997
Firm
Compare
Portfolio
Employees

Investments

Neurala
Neurala
Series A

Total Raised

$32.1M

Rounds

6

Series A$12MJune 2021
Series A$14MJanuary 2017
Kaia Health
Kaia Health

Total Raised

$123M

Rounds

5

Series C$75MApril 2021
Series B$26MJune 2020
Stockly
Stockly
Series A

Total Raised

$17.7M

Rounds

5

Seed$5.1MMarch 2021
Transcend
Transcend

Total Raised

$33M

Rounds

4

Series A$3MAugust 2020
Lifebit Biotech
Lifebit Biotech

Total Raised

$70.6M

Rounds

5

Series A$7.5MApril 2020
Acinq
Acinq

Total Raised

$9.7M

Rounds

2

Series A$8MOctober 2019
WeRide
WeRide

Total Raised

$1.1B

Rounds

6

Series AOctober 2018
October
October
Acquired

Total Raised

$554.7M

Rounds

8

Series Unknown$37MJune 2018
Organica Water
Organica Water

Total Raised

$42.7M

Rounds

5

Series D$21MFebruary 2018
Series C$9.1MJuly 2015
Ifeelgoods
Ifeelgoods

Total Raised

$17M

Rounds

3

Series Unknown$6MJune 2016
Series A$9.5MJune 2011
SmartAngels.fr
SmartAngels.fr

Total Raised

$4.5M

Rounds

2

Series A$3.5MJune 2016
Angel$1MApril 2014
SightCall
SightCall

Total Raised

$54.4M

Rounds

4

Series A$8.4MOctober 2015
Seed$4MJune 2011
Sunrun
Sunrun
Public

Total Raised

$2.9B

Rounds

19

Series UnknownJuly 2015
Criteo
Criteo
Public

Total Raised

$270M

Rounds

4

Public$251MOctober 2013
Lyatiss
Lyatiss

Total Raised

$3.3M

Rounds

1

Series A$3.3MMay 2012
Prudent Energy
Prudent Energy
Public

Total Raised

$51.5M

Rounds

2

Series Unknown$29.5MOctober 2011
Santen Ventures
Santen Ventures
Public

Total Raised

$59M

Rounds

6

Post Ipo Equity$15MSeptember 2009
Zealand Pharma
Zealand Pharma
Public

Total Raised

$1.9B

Rounds

7

Series UnknownFebruary 2005
Schneider Electric
Schneider Electric
Public

Total Raised

$1.6M

Rounds

3

—December 2004